Codela Broncho (and neo): description, instruction, application for children. Neo-bronchol - Instructions for the use of prices and analogues

Most pathologies, in the clinical picture of which there are cough syndrome, can be eliminated by expectorant and antitussive drugs. When selecting medicines, the type of cough must necessarily take into account. This symptom is wet or dry. Among the most popular funds are distinguished by Codela Croncho with a chamber, Codelak Neo and the ACC. Despite the relative security of these medicines, patients should not ignore the advice of the attending physician and the prescriptions of the manufacturer. Instructions for use must be attached to each of the listed funds.

Codelat Broncho

Codela Croncho is a brown syrup. With long-term storage at the bottom of the bottle, a precipitate may form. Therapeutic composition includes the following ingredients:

• sodium glycyrrizinate;
• castabre extract in liquid form;
• ambroxol hydrochloride;
• propyl paragidroxybenzoate;
• sorbitol;
• methyl apograproxybenzoate.

Elixir is placed in glass bottles. To quickly dial the required amount of medication, use a dimensional spoon, which is placed in cardboard packaging. The drug is prescribed if there are a history of such ailments as:

• pneumonia;
• obstructive pathology of the lungs;
• bronchiectatic diseases;
• chronic and acute bronchitis.

Thanks to this medicine, the wet is much easier, and well-being is significantly improved.

Codelk Broncho - Russian combined drugcharacterized by expectorant, mercolitic and anti-inflammatory properties. It normalizes the ratio of the ingredients, dilutes the sputum accumulated in bronchi, and makes it easier for it. With regular medication, a membrane-stabilizing, cytoprotective and antioxidant action is observed.

It often includes vocabulary extract. Thanks to it healing properties Eliminate muscle spasms. The useful effect of the medication is due to essential oils. There are no structural analogues from Codelaka Broncho. If there are contraindications, the drug is replaced by another medicine. His selection is engaged in the attending physician.

https://youtu.be/fapkml_j7xc.

What can replace the codelk bronchi

Codelk neo

Codelk neo is also implemented in the form of a suspension. The drug is based on the bayamirat citrate. Positive effect The active component is enhanced by means of auxiliary ingredients. This type of Codelaka is prescribed when the diseases of the respiratory system are progressing with dry cough attacks. A strong reason for his reception becomes bells, preparations for conducting diagnostic procedures.

Codelak neo is characterized by a powerful antitussive effect. Neuroidal compound inhibits coughing syndrome and stops inflammatory process. With regular use of the medication, an increase in the indicators of spirometry and the saturation of the body with oxygen. The maximum concentration of the active component is fixed after 1.5-2 hours after receiving the codec. The medication is removed from the body by the urinary system. Syrup can be bought in any stationary pharmacy, the recipe is not required. The only substitute for the code is considered a sysecode.

After several techniques of the ACC, the cough intensity is significantly reduced. As a result, the process of cleanement becomes more productive. The medicine helps with serious hereditary agers, fibrous in them is counted. The ACC is rendered good effect With trachekit, swivel, riti of acute character, rinoparing.

An annotation attached to the ACC is indicated that this drug has no age limit. In the list of indications for use is present:

The ACC has detoxifying and mercolytic properties. He is prescribed to adults and children suffering from strong cough. The ACC effectively dilute the mucus, quickly displays it from the respiratory tract, improves the secret engine function. This medicine is included in the group of budgetary medicines. The ACC is produced in several forms, among them syrup, powder, pills and capsules. The spectrum of the action of this medicinal product is quite wide. The composition of the mucus does not have much importance, the ACC helps to get rid of even from purulent sputum.

The pharmacological product when treating treatment can be replaced by the following medicines:

• ACS LONG;
• Fluimucil;
• Azestin;
• Ambroben;
• Lazolyvan.

The list can be complemented by Mukosol, Linkas, Svin, Mountains and acetud.

How to accept

Take Codela Broncho with a chamber need before eating. One-time standard depends on the age of the patient, the course lasts no more than 7 days. Violation of the prescribed therapeutic scheme is fraught with the development of overdose. This state is characterized by the occurrence of dyspeptic disorder and allergic reaction.

To eliminate the negative effects of the patient, it is necessary to wash the stomach. The procedure is carried out in the first 2 hours after the adoption of an excessively large dose.

• under two years;
• suffering from deficiency of parenchymal organs, asthma, ulcerative disease;
• a history of which is present diabetes (The nature of pathology does not matter).

https://youtu.be/8bzjmwmid6s.

The drug Codelk neo should be applied only after consulting the attending physician. Before the start of the therapeutic course, the patient should be familiar with the instructions for use. Contraindications include:

• individual intolerance to the current component;
• childhood (less than 3 years);
• combining several musolithic preparations.

The medication is designed for oral reception. Codelk Neo needs to drink several times a day before meals. Suspension is used in non-diluted form. The drug is not prescribed by pregnant and lactating women. Ignoring the Doctor's recommendations is fraught with the appearance adverse Reactions. Complications can touch:

Against the background of reception of drugs from cough may occur strong headache

• CNS - loss of orientation in space, weakness in the whole body, severe headache, drowsiness during daytime, apathy;
• skin cover - allergic rash, swelling of mucous membranes, itching;
• the gastrointestinal tract is the loss of appetite, painful sensations in the stomach, nausea, vomiting, excessive gas formation.

The ACC gives the maximum good effect when wet cough. Thanks to the rapid elimination of the accumulated viscous mucus, the health of the child is significantly improved. From the drug produced in the form of granules or powder, prepare therapeutic fluid. Children's ADC are implemented in the form of tablets. Before use, they are dissolved in a small amount of water. The finished solution is often used as an inhalation solution.

When using everyone medicinal preparation clinical picture complemented by anemia and jumps arterial pressure. To eliminate pathological changes, the patient is prescribed symptomatic therapy. To complications that arose as a result of the interaction of Codelaka Neo (ACC, Codelaka Broncho) and other medicines, are counted secondary bacterial infection and broncho-construction.

It is categorically prohibited to engage in self-treatment. If there is no therapeutic effect, the patient is directed to an additional examination.

Composition and form of release of the drug

10 pieces. - Packaging cell contour (2) - packs cardboard.

pharmachologic effect

Mukolithic and expectorant, is an active N-demethylated metabolite. It has secretomotor, secretolithic and expectorant action. Stimulates the serous cells of the bronchi mucosa, increases the motor activity of the flicker epithelium by influencing the type 2 pneumocytes in alveoli and the Clara cells in bronchioles, enhances the formation of an endogenous surfactant - surfactant that provides a gliding bronchial secretion in the lobes of respiratory tract.

Ambroxol increases the share of the serous component in the bronchial secret, improving its structure and contributing to a decrease in viscosity and wet wet; As a result, mukiciliary transport improves and relieves the removal of sputum from the bronchial tree.

When receiving an ambroxol inside the effect, on average, it occurs after 30 minutes and lasts 6-12 hours, depending on the one-time dose.

Pharmacokinetics

After taking inside, ambroxol is quickly and almost completely absorbed. T Max is 1-3 hours. Binding of proteins is approximately 85%. Penetrates the placental barrier, stands out from breast milk. Metabolized in the liver with the formation of metabolites (dibromantranyl acid, glucuronic conjugates), which are removed by the kidneys. It is removed mainly by the kidneys - 90% in the form of metabolites, less than 10% unchanged. T 1/2 of the plasma is 7-12 h. T 1/2 of ambroxol and its metabolites is approximately 22 hours.

Due to high binding to proteins and large V D, as well as slow inverse penetration from tissues to blood, during dialysis or forced diurea, the substantial removal of ambroxol does not occur. Clearance of ambroxol in patients with severe decreases by 20-40%. With severe renal failure T 1/2 Metabolites ambroxol increases.

Indications

For receiving inside

Respiratory diseases, accompanied by the release of viscous sputum and the difficulty of wetting the sputum: acute and chronic bronchitis; pneumonia; ; bronchiectatic disease; COPL.

For in / in administration

Respiratory diseases with viscous sputum excretion and with difficulty wetting wet when it is necessary to get a quick therapeutic effect Or impossible to take the drug inside: sharp and chronic bronchitis; pneumonia; bronchial asthma; bronchiectatic disease; Stimulation of the synthesis of surfactant in respiratory distress syndrome in premature babies and newborns (as part of complex therapy).

Contraindications

Increased sensitivity to ambroxol or auxiliary components of drugs; I trimester of pregnancy; lactation period ( breastfeeding); congenital fructose intolerance (for dosage formscontaining fructose); Children's age up to 6 years (for tablets); Children's age up to 12 years (for capsules of prolonged action).

Carefully:bronchial motility violation and increasing mucus secretion (for example, with rare fixed cilia syndrome); renal failure and / or severe liver failure; ulcerative disease Stomach I. duodenal gut (including a history); II and III trimesters of pregnancy; Children's age up to 2 years (solution for intake; only by appointment of a doctor).

Dosage

The duration of treatment is determined by the doctor individually and depends on the severity of the disease. If you need to use the drug more than 4-5 days, a doctor's advice is required.

For receiving inside

Take inside after meals with sufficient liquid.

Dosage forms of the usual duration of action (tablets, syrup, solution for receiving inside, pasteili)

Adults and children over the age of 12:30 mg 2-3 times / day for the first 2-3 days, then 30 mg 2 times / day.

Children aged 5 to 12 years: 30-45 mg / day in 2-3 reception.

Children aged 2 to 5 years:22.5 mg / day in 3 reception.

Children under 2 years old:15 mg / day in 2 reception. The drug is prescribed only under the control of the doctor.

Capsules of prolonged action

Adults and children over 12 years old: 75 mg 1 time / day.

For in / in administration

Enterv / in slowly inkjet or drip.

Adults:30-45 mg / day, 2-3 times / day in divided doses. In severe cases, the dose can be increased 60-90 mg / day, 2-3 times / day in divided doses.

For childrenthe daily dose is, as a rule, 1.2-1.6 mg / kg body weight.

Children over 6 years old:30-45 mg / day, 2-3 times / day in divided doses.

Children aged 2 to 6 years:22.5 mg / day, 3 times / day in divided doses.

Children under 2 years old:15 mg / day, 2 times / day in divided doses.

For respiratory distress syndromew. newborn and premature babies The daily dose is 30 mg and, as a rule, is distributed to 4 separate injections.

Treatment children under 2 years old It should be carried out only under the control of the doctor.

Parenteral use stop after disappearance acute manifestations Diseases and switch to the reception of Abmroxol inside in the appropriate dosage forms.

W. patients with renal failure and heavy renal failure Ambroxol should be applied with longer intervals or reduced doses.

Side effects

Allergic reactions: rarely - skin rash, urticaria, examine, swelling of face, shortness of breath, itching, temperature rise; The frequency is unknown - anaphylactic reactions, including anaphylactic shock, angioedema edema, skin itch, Allergic contact dermatitis.

From side digestive system: often - nausea; Infrequently - vomiting, diarrhea, dyspepsia,.

From side nervous system: Often - disgusting.

From the side of the skin and subcutaneous fabrics: Very rarely - toxic epidermal necroliz (Layella syndrome), Stevens-Johnson syndrome; The frequency is unknown - a sharp generalized eczematosis empty.

From the respiratory system: Often - reduced sensitivity in the oral cavity or pharynx; Rarely - dryness of the mucous membrane of the respiratory tract, Rinorea; In isolated cases - dryness of the mucous membrane of the pharynx.

Medicinal interaction

Antitussive tools (for example, codeine) - Due to the suppression of the cough reflex, it is possible to climb the sputum in the lumen of the respiratory tract with the difficulty of its removal (simultaneous use is not recommended).

, doxycycline, cefuroxime, erythromycin - Increasing the penetration of antibiotics into the bronchial secret.

special instructions

Ambroxol should not be taken simultaneously with antitussive preparations, which can slow down the cough reflex, for example, with codeine, because This may impede the removal of a liquefied sputum from the bronchi.

With caution, an ambroxol should be used in patients with a weakened cough reflex or impaired mucocyllure transport due to the possibility of clustering sputum.

Do not take ambroxol immediately before bedtime.

In patients with bronchial asthma, Ambroxol can enhance cough.

In patients with severe skin lesions - Stevens-Johnson syndrome or toxic epidermal necrolism - in the early phase there may be flu-like condition: temperature, pain in the body, rhinitis, cough, pharyngitis. In symptomatic therapy, it is possible that the erroneous purpose of the musolithic agents, such as ambroxol hydrochloride, is possible.

Pregnancy and lactation

Ambroxol is contraindicated in the first trimester of pregnancy. If necessary, use in the II and III trimesters should evaluate the potential benefit of therapy for the mother and possible risk For fetal.

If necessary, the use of ambroxol during the lactation period should be resolved about the cessation of breastfeeding.

Childcare

Application is possible in accordance with the dosing regimen.

Application in old age

The drug is allowed for use in elderly patients.

Codelak - an expectorant and antitussive drug, which is used in the treatment of respiratory pathologies, accompanied by a difficult wet wet branch.

Composition, release form, packaging

The drug is produced in the form of tablets of 10 pieces in 1 package. There are also varieties of the drug - Codelak Broncho and Codelak Neo.

These types of funds are produced in the form of syrups, elixirs, tablets. The active ingredients are codeine, sodium bicarbonate, licorice root, lanceal thermopsis grass.

In a variant of the preparation "Broncho" is also present instead of Codein of ambroxol hydrochloride, vacam extract, glycyrrhizinic acid. The Neo Oo Codec contains citrate butamirate.

Manufacturer

The manufacturer is the Russian company Pharmstandard.

Indications

Indications are states accompanied by wet and with the difficult separation of the secretion of the respiratory tract.

Used in the pathologies of respiratory tract - colds and to pneumonia of various etiologies. The highest efficiency means with an unproductive cough.

Contraindications

Contraindications to use are the following states:

• Hypersensitivity;
• Bronchial asthma;
• Respiratory failure;
• Age less than 2 years for syrup;
• Age less than 2 months for droplets;
• Children's age up to 2 years for tablets;
• Pregnancy (especially I trimester), lactation;

Mechanism of action

The Codela in the classical version in the composition contains codeine, which is a narcotic analgesic with a pronounced antitussive effect. It reduces the excitability of a cough center.

This contributes to the elimination of an unproductive cough. In doses exceeding the recommended, the substance can coagulate the respiratory function.

The thermopsis grass has an action on respiratory and vomiting centers, and also contributes to sputum. As a result, the secret is naturally eliminated by their respiratory organs.

Sodium bicarbonate changes the pH of the mucus, making it alkaline. As a result, the viscosity of sputum decreases. The root of licorice has a pronounced expectorant effect, stimulating the camcorder epithelium and enhancing the secretory activity of the Bronchi gland.

Having also a minor antispasmodic effect, the extract contributes to a decrease in tone smooth muscles respiratory tract.

The therapeutic effect develops in half an hour and hour and lasts up to 6 hours.

What preparations are better to treat cough in a child, tells Dr. Komarovsky:

Instructions for use

Tablets are accepted 1 piece up to 3 times a day. One-time maximum - 50mg Codeine, daily - up to 200mg. The course lasts about 3-5 days.

Syrium is accepted:

• 3-6 years - 5ml 3 times a day;
• 6-12 years old - 10ml 3 times a day;
• 12-18 years old - 15ml 3 times a day;
• Adults are given 15ml 4 times a day.

The drip form is also given according to age:

• 2-12 months - 10 drops (per day 4 times);
• 1-3 years - 15 drops (4 times a day);
• Older 3 years - 25 drops (per day 4 times)

All forms are accepted, regardless of food and time of day. In general, it is recommended to make the last reception within 6 hours before sleep.

Side effects

Side effects manifest often, but may arise in the form of epilepsy and brain diseases. The drug is able to influence the ability to control transport and complex mechanismsTherefore, when conducting a course, it is impossible to engage in such activities.

Medicinal interaction

Any interactions are not described by the manufacturer. But it is still not recommended to use Codela in parallel to neuroleptics, tranquilizers, sleeping pills, or other means that oppress the CNS.

"Codelk Broncho" with vacambum extract and "Codelak Neo" - drugs used in cough. If necessary, the first drug is prescribed to achieve a viscosity of viscous sputum, if you need to stop unproductive coughing shoes, the form "Codelak Neo" is applied.

In both cases, drugs do not contain opioid components, so practically without difficulty are used in children's practice.

The composition of "Codelak Broncho" is represented by synthetic substances (especially ambroxol), as well as vegetable components (chamber and thermopsis) that dilute viscous sputum. Additional effects on the reduction of inflammation and healing of microtrase mucosa of the bronchi are ensured by the presence of glycyrrhizic acid and vocabulary.

The basis of "Codelk Neo" is butamirat (Substance, selectively depressing cough center). Its use accurately suppresses the reflex at the level of the oblong brain without affecting other CNS structures.

Is it possible to give children

Preparations exist in various forms. The possibility of application is caused by the anatomy-physiological characteristics of the growing children's body. The minimum age in which it is possible to use the drops of "Codelk Neo" or the Elixir "Codelak Bronchon" with the addition of vocabulary, respectively amounts to 2 and 24 months.

Indications for use

"Codela Croncho" is prescribed in pathological conditions by the respiratory system, accompanied by the presence of a difficult sputum:

• Bronchiectatic disease (inflammation of extended sections in bronchi).
• Chronic bronchorate (COPD).

"Codelak Neo" is assigned to eliminate the painful dry cough with the following states:

• ORVI.
• Whooping cough.
• During preoperative preparation and in the period after the operation.
• Before diagnostic studies when you need to suppress the physiological cough reflex.

Forms of release of drug

Production "Codela Broncho" for children is carried out as an elixir (vials of 50, 100 and 125 ml with a spoon), as well as in tableted form of 10 and 20 pcs. packaged.

"Codelak Neo" has a greater number of output:

1. Drops in 20 ml bottles with dispenser.
2. Syrup, 100 and 200 ml bottles with an attached measurable spoon.
3. Tablets 0.05 g (over 18 years).

Instructions for use

"Codela Broncho" with vacific extract:

• Starting from 2 years of age in the form of an elixir - a one-time dose of 2.5 ml, three times applied per day. Children are 6-12 years old - 5 ml three times per day.
• Since 12 years old and adults can drink 1 tablet 3 times a day, or 10 ml of elixir 4 times a day.

It is worth noting that there is a means of "Codelk Broncho" with a slightly different composition (only thymes are indicated among the plant components). This medicine is applied only from 12 years.

• Kids from 2 months to 1 year inclusive - 10 drops 4 times a day.
• From 1 to 3 years - 15 drops fourfold per day.
• From 3 years - 25 drops 4 times in 24 hours, or in the form of a syrup 5 ml 3 times a day.
• The child is 6-12 years old - 10 ml with multiplicity 3 times a day.
• From 12 years before reaching the 18th anniversary - 15 ml three times a day.

The total duration of treatment is about 5 days.

Structure

"Codelak Neo" has at the heart - salt ButamirataIt additionally contains stabilizers, preservatives, vanillin and 96% alcohol.

"Codela Croncho" is presented ambroxol, Glycyrrhizinic acid and vegetable components in the form of extracts of vocabulary and thermopsis.

Side effects

For increased content Drug components in the blood can develop dyspeptic manifestations.
The appearance of rashes during allergization components of these drugs is not excluded.

Contraindications

The presence of individual intolerance this medicine In history. The lactation period and pregnancy. Age restrictions in accordance with the appointed form (2 or 24 months).

Analogs

"Codelk Broncho" with the extract of the Cabinet does not have perfect analogues. Ambroxol is presented in various forms in the form of "Lazolyvan", Khalixola. The chamber and thermopsis are sold in the form of cough tablets and herbs for brewing on a steam bath.

Butamirat is part of the "syncode", on use in accordance with age criteria corresponds to " Posolka neo" There is syrup "Omnitus", which can be given only from 3 years.

LSR-007558 / 08-180908

International unpatient name (MNN): Ambroxol

Chemical name:
Trans-4 - [(2-amino) -3,5-dibrombenzyl) amino] -Cyclohexanol hydrochloride

Dosage form:

Tablets for resorption without sugar.

Structure:

1 tablet for resorption without sugar contains active substance: 15 mg of ambroxol hydrochloride and auxiliary substances: acacia, sorbitol solution 70%, peppermint oil oil, eucalyptus of leaves oil, sodium sodium saccharite dihydrate, paraffin liquid, purified water.

Description:
Round, convex on one side and concave on the other side of the tablet with a rough surface of light brown with a slight mint aroma.
The uneven staining is allowed, the presence of air bubbles in the tablet mass, minor irregularities of the edges.

Pharmacotherapeutic Group:

Mukolithic, expectorant.

ATX code: R05CB06.

Pharmachologic effect:
The musolitic agent, stimulates the prenatal development of the lungs (increases the synthesis, the secretion of the surfactant and blocks its decay). It has secretomotor, secretolithic and expectorant action; stimulates the serous cells of the glance of the bronchi mucous membrane, increases the content of the secrecy of the secret and the release of the surfactant (surfactant) in the alveoli and bronchi; normalizes the disturbed ratio of the serous and mucous components of sputum. Activating hydrolyzing enzymes and enhanced release of lysosomes from Clara cells reduces the viscosity of sputum. Increases the motor activity of the fiscal epithelium, increases mukicillion transport. After receiving inside the action occurs after 30 minutes. And continues within 6-12 hours.

Pharmacokinetics:
Absorption is high (with any introduction paths), the time to achieve maximum concentration in the blood is 2 hours, the connection with plasma proteins is 85%. Penetrates through the hematorecephalic barrier, the placental barrier, stands out with breast milk. Metabolism - in the liver, forms dibromantranyl acid and glucuronic conjugates. The half-life of T1 / 2 - 7 - 12 hours is excreted by the kidneys: 90% in the form of water-soluble metabolites, unchanged - 10%. T1 / 2 increases by 20 - 40% with severe chronic renal failure (CPN), does not change when the liver function is disrupted.

Indications for use:

Respiratory diseases accompanied by the allocation of a viscous and difficult secret: acute and chronical bronchitis, pneumonia, COPD (chronic obstructive pulmonary disease), bronchial asthma with difficulty wetting, bronchootathic disease.

Contraindications:

Hypersensitivity.

Pregnancy: 1 trimester.

Children under 6 years old. Carefully
hepatic insufficiency, renal impairment, ulcerative disease of the stomach and duodenum, pregnancy (II - III trimester), lactation period.
In the case of rarely encountered bronchial diseases associated with overpressions of sputum, neo-bronchol ® should be used with extreme caution, under the supervision of the doctor.

Method of use and dose:

Pills for resorption without sugar
Children from 6 to 12 years old:
Space on one tablet (15 mg) 2-3 times a day. Do not receive more than 3 tablets for resorption for 24 hours (corresponds to 45 mg of ambroxol hydrochloride).
Adults and children over 12 years old:
Dissatting two tablets (30 mg) 3 times a day for the first 2-3 days. Do not take more than 6 tablets within 24 hours. Next, it is recommended to take 1 tablet 3 times a day.
Tablets take after eating and dissolve until complete dissolution.
To achieve a larger mercolytic effect, during therapy it is necessary to consume a sufficient amount of fluid.
Do not take neo-bronchol ® more than 4-5 days without an indication of the doctor.
Note for diabetes patients:
1 Tablet for resorption without sugar neo-bronchol ® contains a 70% solution of sorbitol (not crystallized), 922.2 mg (dry matter), which corresponds to 0.08 x (bread units). Side effects:
From the gastrointestinal tract:rarely - nausea, diarrhea, constipation, gastralgy, vomiting.
Allergic reactions:skin rash, itching, urticaria, contact dermatitis, in isolated cases - anaphylactic shock, angioedema swelling, examine.
From the respiratory system: Dry B. respiratory tract
From the urinary system: Dysuria.
Others:weakness, headache, Rinorea.
When appearance side Effects It is necessary to stop taking the drug and consult a doctor.

Overdose:

Symptoms: Nausea, vomiting, diarrhea, dyspepsia.
Treatment: Artificial vomiting, washing the stomach in the first 1-2 hours after receiving the drug, the reception of grease-containing products.

Interaction with other drugs:

Sharing with antitussive drugs leads to the difficulty of the wetting of sputum against the background of decreasing cough. Increases penetration into the bronchial secret of amoxicillin antibiotics, cefuroxime, erythromycin, doxycycline.

Release form:

Tablets for resorption without sugar 15 mg. 10 tablets in a blister from PVC film (polyvinyl chloride) and aluminum foil; 2.3 or 4 blisters along with instructions for use in a cardboard pack.

Storage conditions:

At temperatures not higher than + 25 ° C, in a dark place.
Keep out of the reach of children.

Shelf life:

4 years.
Do not use the preparation with an expired expiration date. Vacation from pharmacies:
Without recipe.

Manufacturer:

"Bulder Arznaimizer GmbH and Co. kg" Koblenzer Schtr. 65, 50968 Cologne, Germany Firm-owner registration certificate: "Divafarma GmbH" Motomere Str. 41, 12277 Berlin, Germany Representation in the Russian Federation:
Representation of the company MAVI GMBH, 119048, Moscow, Luzhnetskaya Embankment, 24, structure 9.